Vivid Microscopy Tech Detects Stages of Cardiac Microvascular Disease, Study Shows
Vivid Microscopy's high content screening probe tech was successful in a study on coronary microvascular disease in post-menopausal women.
Category: Cardiovascular
Cardiovascular
Latest
Cardiovascular
Latest
New Recommendations on Genetic Testing for Inherited Cardiac Diseases
When exactly patients should undergo genetic assessment for a heart condition was recently detailed in an international consensus document.
Cardiovascular
Latest
Prospera Heart Transplant Assessment Test Validated, Launched
Natera, Inc. has announced the validation and availability of its Prospera Heart transplant assessment test for heart transplant recipients.
Routine Blood Sugar Test Identifies Advanced Atherosclerotic Disease
The routine use of the glycosylated hemoglobin test to track blood sugar levels can identify those with more advanced atherosclerotic disease.
Read More
Zora Biosciences Licenses Ceramide Technology to Quest Diagnostics
Quest plans to develop a test service based on Zora’s ceramide technology as an aid in identifying patients at risk for cardiovascular-related disease and death.
Read More
Verichem Releases Ready-To-Use HDL/LDL Calibration Verification Kit
Verichem’s HDL Cholesterol Verifier Kit contains HDL and LDL cholesterol and other lipid components from human serum free of potential interfering substances.
Read More
New Cardiovascular Risk Assessment for Patients with Rheumatoid Arthritis
Myriad Genetics’ Vectra Cardiovascular Risk assessment can predict the risk for cardiovascular events in patients with rheumatoid arthritis.
Read More
Webinar: Implementing High-Sensitivity Troponin Testing: Multiple Stakeholders, Multiple Perspectives
Join Clinical Lab Products for this free webcast, sponsored by Beckman Coulter, which provides an overview of high-sensitivity troponin I testing.
Read More
Vectra Testing, Biomarkers Help Predict Risk for CV Events in RA Patients
Myriad Genetics shared new data further demonstrating that Vectra testing and three additional biomarkers can help predict the risk of cardiovascular events in patients with rheumatoid arthritis.
Read More
Study Offers Promise for Early Detection of Infections among Childhood Leukemia Patients
A noninvasive blood test may provide a ‘crystal ball’ for early detection of infections, leading to increased cure rates among pediatric leukemia patients.
Read More
MU Researchers Identify Potential Cause of Elevated Nighttime Blood Pressure among OSA Patients
Cell secretions may be key to diagnosing and treating nocturnal hypertension.
Read MoreRandox Launches Adiponectin Assay for Metabolic Risk Assessment
The Randox adiponectin assay is a liquid, ready-to-use reagent that can be used on a wide range of clinical chemistry analyzers.
Read MoreNGS Detects Bloodstream Infections in Pediatric Cancer Patients before Symptoms Develop
The Karius test detected bloodstream infections in 75% of cases as early as 3 days before pediatric leukemia patients became symptomatic.
Read MoreFDA Clears High-Sensitivity Troponin-I Blood Test from Abbott
The newly cleared diagnostic could help identify heart attacks several hours sooner than standard troponin tests—and help improve diagnoses in women.
Read More
Randox Introduces sPLA2-llA Assay for Clinical Chemistry Analyzers
Measurement of patient sPLA2-llA levels enables clinicians to gain a comprehensive overview of cardiovascular risk factors and can help them tailor treatment accordingly.
Read More
Mass Spec Test Offers More Accurate Assessment of Heart Disease Risk than Standard Cholesterol Tests
An international study shows that LDL cholesterol is unable to predict future cardiovascular events and fails to identify patients at the highest risk.
Read MoreStaying on Target
This companion article discusses American Diabetes Association targets for the blood glucose levels of diabetic patients, as measured with an HbA1c test.
Read More
High-Sensitivity Troponin I Test Helps to Predict Future Cardiac Events
Research found that Abbott’s high-sensitivity Troponin I blood test may identify adults at risk of having a cardiac event, independent of other heart disease risk factors.
Read More